Delivery Order SPE2DR25D1002-SPE2DR26FGM0B
- Not listed
- The Defense Logistics Agency awarded a $16,697.50 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, non-set-aside contract with a completion date of December 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine commonly used by the Department of Defense for military personnel and beneficiaries requiring immunization protection....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,217.02 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 22, 2025, with an ultimate completion date of December 23, 2025. This delivery order, issued under a firm fixed-price contract type with no set-aside designation, represents a competitive award to the prime contractor. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid...
- The Defense Logistics Agency awarded a delivery order valued at $6,899 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine commonly used for military personnel and federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,339.50 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 18, 2025, with completion scheduled for December 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product used for immunization purposes, reflecting the federal government's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.09 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with completion scheduled for November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine used for immunization purposes within military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,044.10 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with an ultimate completion date of November 19, 2025. TYPHIM VI is a typhoid vaccine product, and this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.86 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine used primarily for military personnel and federal healthcare beneficiaries....
- The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,174.25 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement of a specific pharmaceutical product to be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine indicated for immunization against typhoid fever,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,614.20 with a completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the company's role in supplying...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM0BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,009.25 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 29, 2025, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine indicated for immunization against typhoid fever, commonly procured for military personnel and deploying service members who require vaccination protection. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen's DLA contract portfolio demonstrates its extensive capability to fulfill federal medical supply requirements across multiple therapeutic domains for defense and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/28/25 |